RxDoctor Payments DataLook up a doctor →

Gregory Egnaczyk, MD

Advanced Heart Failure and Transplant Cardiology · Cincinnati, OHNPI 1174513733

Payments from drug & device makers

$219,121in general payments, 2019–2025

Across 559 payments — averaging $391.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$100K
  • Abbott$61K
  • Medtronic$44K
  • AstraZeneca$7K
  • Boston Scientific$5K
  • Novartis$580
  • plus $1K from 18 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$219,121 in reported general payments places this provider in the 75th percentile of 62 advanced heart failure and transplant cardiology providers in Ohio.

See all advanced heart failure and transplant cardiology providers in Ohio

Medicare billing

Part B allowed, 2024
$152,325
Medicare patients
845
Services billed
2,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →